Gastric Pharm Flashcards
sucralfate
chemical diffusion barrier drug
- sucrose octasulfate polymerizes forming a paste that binds to damaged gastric epithelium
- forms a physical barrier against stomach acid
H2 receptor function
H2 receptor is located on parietal cells and regulates histamine-mediated gastric acid secretion
famotidine
3rd generation H2 selective antagonist from Merck
omeprazole
proton-pump inhibitor
supplied as an enteric-coated capsule to survive the stomach
- once in the low pH environment around the parietal cell, it becomes protonated
- protonated form of the drug binds covalently and irreversibly to and inactivates the proton pump
omeprazole efficacy
it has a short half life by its efficacy lasts longer than predicted from plasma drug concentration (activity is still present despite not having a plasma concentration)
pantoprazole
proton pump inhibitor
- weak base, like omeprazole
- supplied as a delayed-release tablet and delayed-release granules to survive the stomach
- same mechanism as omeprazole
promotility drugs
help control acid reflux by strengthening the lower esophageal sphincter, decreases stomach emptying time allowing less time for reflux to occur, stimulates smooth muscle contraction of stomach to speed emptying allowing less time for reflux to occur
cisapride
promotility drug
- 5HT4 serotonin receptor agonist that directly stimulates gastric motility
- increases the release of Ach nerve endings in the myenteric plexus controlling gut motility in the ENS
metoclopramide
promotility drug
- D2 antagonist (dopamine type 2 antagonist)
- results in increased LES and stomach tone
- results in increased nerve terminal Ach release and therefore increased Ach-mediated gastric motility
erythromycin and azithromycin
promotility drug
- antibiotics that are weak agonists for the Motilin receptor
- motilin binding to the motilin receptor on enteric neurons stimulates gastric motility
ranitidine and nizatidine
promotility drugs
weak inhibitors of acetylcholinesterase
blocking acetylcholinesterase results in increased Ach synapse increasing gastric motility
chlorpromazine
antiemetic, alpha 2 adrenergic antagonist
metoclopramide
antiemetic that blocks D2 receptors in the brain
ondansteron
antiemetic drug, blocking 5HT3 serotonin receptors in the brain and gut
Maropitant (cerenia)
antiemetic, blocks NK-1 receptor activation in brain to reduce vomiting